Audit 356124

FY End
2024-12-31
Total Expended
$11.48M
Findings
0
Programs
35
Year: 2024 Accepted: 2025-05-13

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.077 Family Smoking Prevention and Tobacco Control Act Regulatory Research $1.02M Yes 0
93.088 Advancing System Improvements for Key Issues in Women's Health $819,643 - 0
93.136 Injury Prevention and Control Research and State and Community Based Programs $268,632 - 0
84.425 Education Stabilization Fund $206,313 - 0
93.110 Maternal and Child Health Federal Consolidated Programs $177,319 - 0
93.592 Family Violence Prevention and Services/discretionary $141,194 - 0
93.788 Opioid Str $133,702 - 0
84.373 Special Education Technical Assistance on State Data Collection $104,715 Yes 0
16.838 Comprehensive Opioid, Stimulant, and Other Substances Use Program $76,434 - 0
93.958 Block Grants for Community Mental Health Services $73,696 - 0
93.959 Block Grants for Prevention and Treatment of Substance Abuse $70,166 - 0
84.326 Special Education Technical Assistance and Dissemination to Improve Services and Results for Children with Disabilities $68,981 - 0
93.087 Enhance Safety of Children Affected by Substance Abuse $66,931 - 0
93.273 Alcohol Research Programs $62,920 Yes 0
93.989 International Research and Research Training $53,256 Yes 0
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $51,869 Yes 0
93.350 National Center for Advancing Translational Sciences $50,424 Yes 0
93.866 Aging Research $41,915 Yes 0
93.242 Mental Health Research Grants $41,667 Yes 0
93.527 Grants for New and Expanded Services Under the Health Center Program $39,317 - 0
93.912 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement $29,948 - 0
93.137 Community Programs to Improve Minority Health $26,758 - 0
93.226 Research on Healthcare Costs, Quality and Outcomes $25,117 Yes 0
93.838 Lung Diseases Research $24,552 Yes 0
93.865 Child Health and Human Development Extramural Research $22,905 Yes 0
93.279 Drug Use and Addiction Research Programs $17,459 Yes 0
93.991 Preventive Health and Health Services Block Grant $14,161 - 0
93.671 Family Violence Prevention and Services/domestic Violence Shelter and Supportive Services $11,187 - 0
93.276 Drug-Free Communities Support Program Grants $11,102 - 0
93.361 Nursing Research $7,595 Yes 0
93.591 Family Violence Prevention and Services/state Domestic Violence Coalitions $7,221 - 0
93.799 Cara Act – Comprehensive Addiction and Recovery Act of 2016 $6,140 - 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $2,934 Yes 0
93.397 Cancer Centers Support Grants $1,816 Yes 0
84.327 Special Education Educational Technology Media, and Materials for Individuals with Disabilities $632 - 0

Contacts

Name Title Type
MND6UJJX4PB3 Gary Klig Auditee
3017552753 Susan Colladay Auditor
No contacts on file

Notes to SEFA

Title: Note 1. Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. De Minimis Rate Used: N Rate Explanation: Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. The Institute has elected not to use the 10-percent de minimis indirect cost rate as allowed under Uniform Guidance. Instead, the Institute uses a negotiated indirect cost rate agreement (NICRA) which was approved by the U.S. Department of Health and Human Services on June 17, 2024. The NICRA includes final indirect rates for the year ended December 31, 2022, and provisional indirect rates for the Institute's use through the year ending December 31, 2025. The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the Federal award activity of Pacific Institute for Research and Evaluation and Affiliates (the Institute) under programs of the Federal Government for the year ended December 31, 2024. Information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). The Schedule presents only a selected portion of the operations of the Institute; accordingly, it is not intended to and does not present the consolidated financial position, changes in net assets or cash flows of the Institute.
Title: Note 2. Summary of Significant Accounting Policies Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. De Minimis Rate Used: N Rate Explanation: Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. The Institute has elected not to use the 10-percent de minimis indirect cost rate as allowed under Uniform Guidance. Instead, the Institute uses a negotiated indirect cost rate agreement (NICRA) which was approved by the U.S. Department of Health and Human Services on June 17, 2024. The NICRA includes final indirect rates for the year ended December 31, 2022, and provisional indirect rates for the Institute's use through the year ending December 31, 2025. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. The Institute has elected not to use the 10-percent de minimis indirect cost rate as allowed under Uniform Guidance. Instead, the Institute uses a negotiated indirect cost rate agreement (NICRA) which was approved by the U.S. Department of Health and Human Services on June 17, 2024. The NICRA includes final indirect rates for the year ended December 31, 2022, and provisional indirect rates for the Institute's use through the year ending December 31, 2025.
Title: Note 3. Assistance Listing Numbers Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. De Minimis Rate Used: N Rate Explanation: Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. The Institute has elected not to use the 10-percent de minimis indirect cost rate as allowed under Uniform Guidance. Instead, the Institute uses a negotiated indirect cost rate agreement (NICRA) which was approved by the U.S. Department of Health and Human Services on June 17, 2024. The NICRA includes final indirect rates for the year ended December 31, 2022, and provisional indirect rates for the Institute's use through the year ending December 31, 2025. When assistance listing numbers are not available, Federal awards are classified in the Schedule based on the U.S. agency prefix and are grouped for major program determination as provided by the Uniform Guidance.
Title: Note 4. Reconciliation of Schedule of Expenditures of Federal Awards to Support Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. De Minimis Rate Used: N Rate Explanation: Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. The Institute has elected not to use the 10-percent de minimis indirect cost rate as allowed under Uniform Guidance. Instead, the Institute uses a negotiated indirect cost rate agreement (NICRA) which was approved by the U.S. Department of Health and Human Services on June 17, 2024. The NICRA includes final indirect rates for the year ended December 31, 2022, and provisional indirect rates for the Institute's use through the year ending December 31, 2025. Some of the Institute's Federal awards provide for both the recovery of allowable costs plus a fee above and beyond the allowable costs. Therefore, the total of Federal expenditures reported in the Schedule does not agree to the amount of support from Federal awards reported in the Consolidated Statement of Activities. The following table reconciles the expenditures in the Schedule to total support from Federal awards for the year ended December 31, 2024: Schedule of Expenditures of Federal Awards $ 11,475,978 Additional support from Federal awards in excess of expenditures 247,176 TOTAL SUPPORT FROM FEDERAL AWARDS $ 11,723,154